A Study of Mevidalen (LY3154207) in Participants With Alzheimer's Disease

Clinical trial NCT06538116 · COMPLETED

Trial details

NCT number: NCT06538116
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2024-08-26
Primary completion: 2026-05-01
Enrollment: 304

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.